NASDAQ (USD): Ensysce Biosciences, Inc. (ENSC)
Last Price
0.721
Today's Change
+0.171 (31.09%)
Day's Change
0.66 - 0.978
Trading Volume
142,548,078
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
OpenAI in Talks With Regulators to Become For-profit Company — Bloomberg
2
US Equity Funds Record Biggest Weekly Outflow in Five Weeks
3
Musk Now Says It's 'pointless' to Build a US$25,000 Tesla for Human Drivers
4
Burger King, KFC Owners Miss Results Estimates as Fast-food Spending Wanes
5
Oil Hedging Activity Hits Record in October as Traders Eye Market Risks
#
Stock
Score
BABA
Alibaba Group Holding Limited
PLTR
Palantir Technologies Inc.
772
SMCI
Super Micro Computer, Inc.
681
BAC
Bank of America Corporation
AGN
454
6
TSLA
Tesla, Inc.
7
CAT
Caterpillar Inc.
8
CUBE
CubeSmart
9
AEM
Agnico Eagle Mines Limited
10
AAPL
Apple Inc.
Last
Change
Volume
WBUY
0.305
+0.19
1,452,480,802
NMHI
0.171
+0.074
415,111,174
XTIA
0.052
+0.002
341,196,541
ELAB
0.018
+0.001
262,880,189
MDJH
0.19
+0.04
171,179,105
ATCH
0.294
+0.114
163,364,636
NVDA
148.33
+2.72
159,620,347
ENSC
+0.171
TRNR
0.071
-0.02
123,366,554
LMDX
0.016
-0.018
120,553,903
FICO
2,172.65
+82.02
179,637
APP
242.14
+73.59
16,447,726
HUBS
656.25
+58.46
1,171,170
MCK
606.55
+57.24
1,942,636
WSO-B
518.97
+48.07
222
MWFLX
47.44
+37.96
0
SITM
224.18
+34.66
467,596
FNGU
522.74
+34.41
903,481
EPAM
234.30
+31.61
1,100,624
RYVLX
574.89
+29.74
BRK-A
692,262.00
-10,738.00
2,426
MELI
1,777.00
-340.30
2,665,347
MPWR
759.30
-160.51
2,985,808
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
FCNCA
2,181.70
-90.92
78,762
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....